Arryx started out from technology invented by Professor David Grier and Eric Dufresne, his student, at the University of Chicago. They were also the ones responsible for the BioRyx 200 which was released in 2002. In 2004, an infrared version of the award-winning optical trapping system was released in 2004 to allow broader applications. It was in 2006 when Arryx was acquired by Haemonetics. It was in 2013 when the company ceased operations.
Arryx, Inc. is a wholly-owned subsidiary of Haemonetics, a global leader in blood management solutions. It was founded in 2000 to develop technology and tools for manipulating and measuring tasks that required nano and micro lenghtscales. Focusing on optical trapping, Arryx specialized in what is known as holographic optical trapping, a technique that allowed the creation and movement of several optical traps at the same time. When the technology was commercialized, it was then known as the BioRyx 200 optical trapping system, a flagship research tool. The BioRyx 200 was tested out to solve various problems in various fields including forensics, basic research, healthcare, agriculture, and telecommunications.
Arryx started out from technology invented by Professor David Grier and Eric Dufresne, his student, at the University of Chicago. They were also the ones responsible for the BioRyx 200 which was released in 2002. In 2004, an infrared version of the award-winning optical trapping system was released in 2004 to allow broader applications. It was in 2006 when Arryx was acquired by Haemonetics. It was in 2013 when the company ceased operations.
0 Comments
|